Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Editorial Commentary: The Use of Allogenic Cells in Regenerative Medicine: Are Amniotic, Umbilical, and Other Allogenic Cell Sources Safe? Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association Dragoo, J. L. 2019; 35 (2): 594–95
Abstract
There are abundant data to suggest that the autologous transplantation of human progenitor cells is safe. However, the use of allogenic cells for human use has not been adequately researched and should not be considered safe at this time.
View details for PubMedID 30712634